Literature DB >> 23732075

Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.

Kazuhiko Ochiai1, Masami Watanabe, Daigo Azakami, Masaki Michishita, Yasunaga Yoshikawa, Chihiro Udagawa, Pornphimon Metheenukul, Thippayarat Chahomchuen, Hiroshi Aoki, Hiromi Kumon, Masami Morimatsu, Toshinori Omi.   

Abstract

REIC/Dkk-3, a member of the human Dickkopf (Dkk) family, plays a role as a suppressor of growth in several human cancers. In this study, the tumour suppression function of canine REIC/Dkk-3 was investigated. The full-length open reading frame of the canine REIC/Dkk-3 homologue was cloned and the tissue distribution of REIC/Dkk-3 mRNA was determined, along with the subcellular localisation of the REIC/Dkk-3 protein in canine cancer cell lines. Expression of REIC/Dkk-3 was lower in mammary gland tumours and in canine mammary carcinoma cell lines than in normal mammary gland tissue. Overexpression of REIC/Dkk-3 induced apoptosis in canine mammary carcinoma cell lines. These results show that expression of REIC/Dkk-3 is downregulated in canine mammary tumours and that one of the functions of this gene is induction of apoptosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Canine; Mammary gland tumours; REIC/Dkk-3; Tumour suppressor gene

Mesh:

Substances:

Year:  2013        PMID: 23732075     DOI: 10.1016/j.tvjl.2013.04.024

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  2 in total

1.  Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines.

Authors:  Yuiko Kato; Kazuhiko Ochiai; Shota Kawakami; Nobuhiro Nakao; Daigo Azakami; Makoto Bonkobara; Masaki Michishita; Masami Morimatsu; Masami Watanabe; Toshinori Omi
Journal:  BMC Vet Res       Date:  2017-06-09       Impact factor: 2.741

2.  Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.

Authors:  Kazuhiko Ochiai; Masami Morimatsu; Yuiko Kato; Toshina Ishiguro-Oonuma; Chihiro Udagawa; Oumaporn Rungsuriyawiboon; Daigo Azakami; Masaki Michishita; Yuichi Ariyoshi; Hideo Ueki; Yasutomo Nasu; Hiromi Kumon; Masami Watanabe; Toshinori Omi
Journal:  Oncotarget       Date:  2016-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.